Paid Clinical Trials Provo

Discover 1,116 paid clinical trials in Provo, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,116

mRNA-3745A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)

Recruiting

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Salt Lake City UT, Edmonton, Houston TX, Cincinnati OHshow 5 more

Code:

NCT05095727

Conditions

Glycogen Storage Disease

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Not accepted

Interventions

mRNA-3745

ProTractX3™ DCBPaclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

Recruiting

PHASE3

Sponsor:

GIE Medical

Location:

Salt Lake City UT, Aurora CO, Colorado Springs CO, Scottsdale AZshow 22 more

Code:

NCT05561127

Conditions

Bowel; Stricture

Eligibility Criteria

Sex: All

Age: 22+

Healthy Volunteers: Not accepted

Interventions

GIE Medical ProTractX3 TTS DCB

Control

Observational StudyEvaluating Intuitive 3D Models in Preoperative Surgical Planning for Thoracic and Colorectal Procedures.

Recruiting

Sponsor:

Intuitive Surgical

Location:

Salt Lake City UT, Columbus OH, Manhasset NY

Code:

NCT06434727

Conditions

Thoracic

Colorectal Disorders

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

observational study

Observational StudyPulmonary Hypertension Association Registry

Recruiting

Sponsor:

Pulmonary Hypertension Association, Inc.

Location:

Salt Lake City UT, Aurora CO, Phoenix AZ, Sacramento CAshow 39 more

Code:

NCT04071327

Conditions

Pulmonary Arterial Hypertension

Chronic Thromboembolic Pulmonary Hypertension

Pulmonary Hypertension

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

TezepelumabEfficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Salt Lake City UT, Aurora CO, Phoenix AZ, Los Angeles CAshow 30 more

Code:

NCT05583227

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo

Isolated Skin VasculitisA Randomized Multicenter Study for Isolated Skin Vasculitis

Recruiting

PHASE2

Sponsor:

University of Pennsylvania

Location:

Salt Lake City UT, Kansas City KS, Dallas TX, Rochester MNshow 11 more

Code:

NCT02939573

Conditions

Primary Cutaneous Vasculitis

Cutaneous Polyarteritis Nodosa

IgA Vasculitis

Henoch-Schönlein Purpura

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Colchicine

Dapsone

Azathioprine

DupilumabA Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting

PHASE2

PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

West Jordan UT, Salt Lake City UT, Reno NV, Phoenix AZshow 42 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

Peripheral NeuropathyEPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy

Recruiting

PHASE2

Sponsor:

James P. Rathmell, MD

Location:

Salt Lake City UT, San Diego CA, Seattle WA, Kansas City KSshow 16 more

Code:

NCT05476276

Conditions

Painful Diabetic Neuropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ISA specific

177Lu-DOTATATE vs. EverolimusComparing Retreatment of 177Lu-DOTATATE PRRT Versus Everolimus in Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Salt Lake City UT, Aurora CO, Albuquerque NM, Phoenix AZshow 22 more

Code:

NCT05773274

Conditions

Metastatic Midgut Neuroendocrine Tumor

Metastatic Midgut Neuroendocrine Tumor G1

Metastatic Midgut Neuroendocrine Tumor G2

Unresectable Midgut Neuroendocrine Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Everolimus

Lutetium Lu 177 Dotatate

Quality-of-Life Assessment

Zongertinib vs. Standard TreatmentBeamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

Recruiting

PHASE3

Sponsor:

Boehringer Ingelheim

Location:

Salt Lake City UT, Bullhead City AZ, Reno NV, Fresno CAshow 17 more

Code:

NCT06151574

Conditions

Lung Cancer, Non-squamous, Non-small Cell

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

zongertinib

pembrolizumab

cisplatin

carboplatin

pemetrexed